DE
CL icon

Day & Ennis’s Colgate-Palmolive CL Stock Holding History

Day & Ennis’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$226K Buy
2,832
+3
+0.1% +$226 0.08% 110
2023
Q3 		$201K Buy
2,829
+3
+0.1% +$224 0.08% 118
2023
Q2 		$218K Sell
2,826
-57
-2% -$4.41K 0.08% 108
2023
Q1 		$217K Sell
2,883
-47
-2% -$3.5K 0.08% 113
2022
Q4 		$231K Buy
2,930
+3
+0.1% +$225 0.09% 103
2022
Q3 		$206K Buy
2,927
+63
+2% +$4.94K 0.09% 103
2022
Q2 		$230K Sell
2,864
-54
-2% -$4.22K 0.09% 101
2022
Q1 		$221K Sell
2,918
-50
-2% -$3.96K 0.07% 117
2021
Q4 		$253K Buy
2,968
+3
+0.1% +$234 0.08% 104
2021
Q3 		$224K Buy
2,965
+2
+0.1% +$159 0.08% 112
2021
Q2 		$241K Buy
2,963
+3
+0.1% +$245 0.08% 108
2021
Q1 		$233K Buy
2,960
+3
+0.1% +$235 0.09% 104
2020
Q4 		$253K Buy
2,957
+2
+0.1% +$165 0.1% 94
2020
Q3 		$228K Hold
2,955
– – 0.1% 91
2020
Q2 		$216K Buy
+2,955
New +$210K 0.11% 86
2019
Q4 		– Sell
-2,801
Closed -$206K – 90
2019
Q3 		$206K Buy
+2,801
New +$203K 0.11% 86

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Day & Ennis's CL Position: Q4 2023 in Review

Day & Ennis increased its Colgate-Palmolive (CL) stake by 0.11% in Q4 2023, buying an estimated $226 and bringing the position to 2,832 shares worth $226K. The position accounts for 0.08% of the portfolio, ranked #110.

Day & Ennis first reported a position in CL in Q3 2019 and has held it in 16 quarters since. The position peaked at $253K in Q4 2021. 1,740 funds tracked by Wall St. Rank hold CL as of Q4 2023.

  • Day & Ennis held 2,832 shares of Colgate-Palmolive worth $226K as of Q4 2023.
  • Day & Ennis bought 3 Colgate-Palmolive shares in Q4 2023, an estimated $226.
  • Colgate-Palmolive made up 0.08% of Day & Ennis's portfolio in Q4 2023, its #110 holding.
  • Day & Ennis first reported a position in Colgate-Palmolive in Q3 2019 and has held it in 16 quarters since.
  • Day & Ennis's Colgate-Palmolive position peaked at $253K in Q4 2021.
  • 1,740 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.

Based on Day & Ennis's 13F filing for Q4 2023, filed 18 Jan 2024.